Clinical Trials Directory

Trials / Completed

CompletedNCT00827736

Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure

Botulin Toxin Versus Isosorbidedinitrate Ointment in Treatment Anal Fissure; A Prospective, Blinded, Randomized Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Onze Lieve Vrouwe Gasthuis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The standard treatment of anal fissure in the netherlands (ISDN ointment) is being compared to a relatively new treatment (injection of Botox in the internal anal sphincter). The study hypothesis is that after 4 months, Botox has healed more patients than ISDN. The comparison is done blinded for the surgeon and the patient.

Conditions

Interventions

TypeNameDescription
PROCEDUREBotoxinjection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline.
DRUGISDN ointmentapplication of ISDN 1% ointment 6 times a day
DRUGPlaceboInjection of placebo into internal anal sphincter (ISDN ointment arm) Applied to the anoderm six times a day (Botox injection arm)

Timeline

Start date
2002-06-01
Primary completion
2006-03-01
Completion
2006-03-01
First posted
2009-01-23
Last updated
2009-01-23

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00827736. Inclusion in this directory is not an endorsement.